Fate Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Fate Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Fate Therapeutics Inc
Rating: 2.13775
Author: Trendlyne DVM scores

about

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline ...

2.21 -0.01 (-0.45%)

New 52W High in past week

3.6M

XNAS Volume

XNAS 04 Jun, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Fate Therapeutics Inc is on 12 Jun 2026 for the purpose of Fate Therapeutics Inc Annual General Meeting for 2026 See details

Not Eligible

Expensive Valuation

15.5 / 100

Technically Moderately Bullish

70.0 / 100

1Yr Price target upside is 145%

9 analysts

Fate Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Fate Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline ...

New 52W High in past week

SWOT Analysis

Fate Therapeutics Inc Live Price Chart